Evidence map›Paper›PMID 29435808›Full record

ArticleMetabolic brain disease2018

Moringa oleifera supplemented diet modulates nootropic-related biomolecules in the brain of STZ-induced diabetic rats treated with acarbose.

Ganiyu Oboh, Sunday I Oyeleye, Omoyemi A Akintemi, Tosin A Olasehinde

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
11.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Molecules (Basel, Switzerland) · 2021
    Pooled it
  2. Potential ofNutrients · 2020
    Pooled it
  3. Nutrients · 2021
    Trial
  4. Article
  5. Article
  6. Review
  7. Frontiers in pharmacology · 2024
    Review
  8. Bioactive Compounds inPlants (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Review on the Antidiabetic Properties ofFrontiers in pharmacology · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ganiyu ObohDepartment of Biochemistry, Federal University of Technology, Akure, Ondo-State, Nigeria. goboh@futa.edu.ng.
Sunday I OyeleyeDepartment of Biochemistry, Federal University of Technology, Akure, Ondo-State, Nigeria. sioyeleye@futa.edu.ng.ORCID 0000-0003-3935-2313
Omoyemi A AkintemiDepartment of Biochemistry, Federal University of Technology, Akure, Ondo-State, Nigeria.
Tosin A OlasehindeNutrition and Toxicology Division, Food Technology Department, Federal Institute of Industrial Research, Oshodi, Lagos, 100261, Nigeria.
Federal University of Technology · NGFederal Institute of Industrial Research Oshodi · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are strong correlations between diabetes mellitus and cognitive dysfunction. This study sought to investigate the modulatory effects of Moringa oleifera leaf (ML) and seed (MS) inclusive diets on biomolecules [acetylcholinesterase (AChE), butyrylcholinesterase (BChE)] angiotensin-I converting enzyme (ACE), arginase, catalase, glutathione transferase (GST) and glutathione peroxidase (GSH-Px) activities, glutathione (GSH) and nitric oxide (NO) levels] associated with cognitive function in the brain of streptozotocin (STZ)-induced diabetic rats treated with acarbose (ACA). The rats were made diabetic by intraperitoneal administration of 0.1 M sodium-citrate buffer (pH 4.5) containing STZ [60 mg/kg b.w (BW)] and fed with diets containing 2 and 4% ML/MS. Acarbose (25 mg/kg BW) was administered by gavage daily for 14 days. The animals were distributed in eleven groups of eight animals as follows: control, STZ-induced, STZ + ACA, STZ + 2% ML, STZ + ACA + 2% ML, STZ + 4% ML, STZ + ACA + 4% ML, STZ + 2% MS, STZ + ACA + 2% MS, STZ + 4% MS, STZ + ACA + 4% MS. There were marked increase in AChE, BChE, arginase, ACE and concomitant decrease in catalase, GST, GSH-Px, activities and NO levels in STZ-diabetic group compared with the control. However, there was a decrease in AChE, BChE and ACE activities and concomitant increase in the antioxidant molecules in the groups fed with supplemented diets treated with/without ACA compared with the STZ-diabetic group. These findings suggest that ML/MS supplemented diet could prevent cognitive dysfunction-induced by chronic hyperglycemia.

Indexed as

AcarboseAnimalsAntioxidantsBlood GlucoseBrainDiabetes Mellitus, ExperimentalHypoglycemic AgentsMaleMoringa oleiferaNootropic AgentsRats, WistarAcarboseAntioxidantsBlood GlucoseHypoglycemic AgentsNootropic AgentsAcarboseCognitive functionDiabetesMoringa oleiferaNeuromodulation

Identifiers

PMID29435808
OpenAlexW2793455268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.